X T L Biopharmaceuticals reported $-479K in EBIT for its fiscal quarter ending in December of 2024.





Ebit Change Date
Alaunos Therapeutics USD -952K 60K Jun/2026
Bioline Rx USD -4.13M 1.79M Jun/2026
Teva Pharmaceutical Industries USD 1.19B 954M Sep/2026
X T L Biopharmaceuticals USD -479K 19K Dec/2024